OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Release Date
2021
(4)
2024
(3)
2022
(3)
2025
(2)
2023
(2)
2020
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Gastrokine-1, an anti-amyloidogenic protein secreted by the stomach, regulates diet-induced obesity.
Not available
S-EPMC8096951
|
biostudies-literature
Cite
Charting the equine miRNA landscape: An integrated pipeline and browser for annotating, quantifying, and visualizing expression.
Not available
S-EPMC12449019
|
biostudies-literature
Cite
Do some patients receive unnecessary parenteral nutrition after pancreatoduodenectomy? Results from an international multicentre study.
Not available
S-EPMC10896679
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.
Not available
S-EPMC7651873
|
biostudies-literature
Cite
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
Not available
S-EPMC10873804
|
biostudies-literature
Cite
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets